About Alignment Healthcare, Inc. - Common Stock (ALHC)
Alignment Healthcare Inc is a leading healthcare company that focuses on providing innovative and personalized health care solutions, primarily for seniors. The company utilizes a technology-driven approach to deliver high-quality, value-based care, ensuring that patients receive tailored support and resources to manage their health effectively. By leveraging data analytics and a network of healthcare professionals, Alignment aims to improve health outcomes while enhancing patient experiences and reducing healthcare costs. The company emphasizes preventive care and proactive health management, positioning itself as a pivotal player in the evolving landscape of healthcare services for aging populations. Read More
NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment” or the “Company”) for potential violations of the federal securities laws.
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
What Happened? Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) fell 14.8% in the afternoon session after the company revealed plans to ...
NEW YORK, July 31, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 31.6% year o...
Alignment Healthcare (NASDAQ:ALHC) reported second-quarter growth in membership, revenue and adjusted EBITDA, while raising the low end of its full-year profitability outlook and increasing its membership expectations for 2026.
Chairman and CEO John Kao said health plan membership reached 294,100 a
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 31.6% year on...
ORANGE, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its second quarter ended June 30, 2026.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment” or the “Company”) for potential violations of the federal securities laws.
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be announcing earnings results this Thursday afternoon. Here’s what to expect. Alignment Hea...
Glancy Prongay Wolke & Rotter LLP today continues its investigation on behalf of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) investors concerning the Company’s possible violations of the federal securities laws after the stock price fell 16% on July 8, 2026.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
